BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Why are inclusion criteria important?
Applying estimands for regulatory precision

Why are inclusion criteria important?
Applying estimands for regulatory precision

Why are inclusion criteria important?
Applying estimands for regulatory precision
Published on Jan 7, 2026
•
•
2 min read time
Inclusion criteria are important in clinical trials because they define the specific characteristics and eligibility requirements that potential participants must meet to be included in the study. This helps to ensure the safety of participants, the validity of study results, and the ethical conduct of the trial.
Some of the reasons why inclusion criteria are important
Participant Safety: Inclusion criteria help identify individuals suitable for the study without undue risk. Excluding certain populations, such as those with pre-existing medical conditions or contraindications to the intervention, reduces the likelihood of adverse events and ensures the safety of participants.
Homogeneity of Study Population: Researchers can create a more homogenous study population by defining clear inclusion criteria. This reduces potential confounding factors and allows more accurate and meaningful comparisons between treatment groups.
Validity of Study Results: Inclusion criteria ensure that participants have the condition or characteristics relevant to the research question being studied. Including only individuals with a specific medical condition or risk factor helps ensure that the study results apply to the intended target population.
Feasibility of the Study: Clearly defined inclusion criteria help researchers identify eligible participants efficiently. This improves the recruitment process and reduces the risk of enrolling individuals who do not meet the study's objectives, which can impact the study's timeline and budget.
Ethical Considerations: Inclusion criteria are essential to protecting participants' rights and ensuring ethical conduct in clinical research. They prevent the enrollment of vulnerable populations, such as pregnant women, children, or individuals unable to provide informed consent, inappropriately.
Regulatory Requirements: Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), require well-defined inclusion criteria for the clinical trial protocol. Meeting these requirements is necessary for obtaining regulatory approval for new medical treatments.
Generalizability of Results: By carefully defining the study population through inclusion criteria, researchers can draw more accurate conclusions about the potential effectiveness and safety of the intervention for the target population. This improves the generalizability of the study results to real-world clinical practice.
Summary
In summary, inclusion criteria in clinical trials are vital for selecting appropriate participants, ensuring participant safety, producing valid and reliable results and adhering to ethical and regulatory standards. Well-defined and appropriate inclusion criteria contribute to the success and credibility of clinical trials.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

Subscribe updates
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®